Search company, investor...

PointCare Technologies

Founded Year



Unattributed VC - II | Alive

Total Raised


Last Raised

$1.8M | 12 yrs ago

About PointCare Technologies

PointCare Technologies is a medical device company building diagnostic devices

Headquarters Location

257 Simarano Drive

Marlborough, Massachusetts, 01752,

United States


Missing: PointCare Technologies's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: PointCare Technologies's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

PointCare Technologies Patents

PointCare Technologies has filed 2 patents.

patents chart

Application Date

Grant Date


Related Topics




Immunology, Clusters of differentiation, Immune system, Flow cytometry, G protein coupled receptors


Application Date


Grant Date



Related Topics

Immunology, Clusters of differentiation, Immune system, Flow cytometry, G protein coupled receptors



PointCare Technologies Frequently Asked Questions (FAQ)

  • When was PointCare Technologies founded?

    PointCare Technologies was founded in 2002.

  • Where is PointCare Technologies's headquarters?

    PointCare Technologies's headquarters is located at 257 Simarano Drive, Marlborough.

  • What is PointCare Technologies's latest funding round?

    PointCare Technologies's latest funding round is Unattributed VC - II.

  • How much did PointCare Technologies raise?

    PointCare Technologies raised a total of $5.4M.

  • Who are the investors of PointCare Technologies?

    Investors of PointCare Technologies include 424 Capital.

  • Who are PointCare Technologies's competitors?

    Competitors of PointCare Technologies include Innara Health, MedShape, Intellirod Spine, Epocal, Minomic International and 15 more.

Compare PointCare Technologies to Competitors


SPOC is a provider of a diagnostic medical device that identifies the specific myofacial (muscle) trigger points that SPOC says are often overlooked by conventional diagnosis which can cause neck and back pain. This device together with the patented clinical methodology developed by Dr. Norman Marcus, SPOC's chief medical officer and engaged in pain management, aim to provide a complete diagnostic package for accurate and precise identification of muscle pain.

NIR Diagnostics

NIR Diagnostics is developing a diagnostic device to quantitatively assess the progress of the wound healing process. Per the company, the device has the potential to be a more accurate, more rapid, and less expensive method of wound assessment compared to those currently on the market.

Modules for Novel Diagnostics

MND Diagnostics is a healthcare company focused on disease diagnosis. The medical device company has developed a diagnostic detection platform which aims to be rapid, low-priced and portable.

Cord Blood Registry Logo
Cord Blood Registry

Cord Blood Registry (CBR) is a newborn stem cell company. CBR is dedicated to advancing the clinical application of cord blood and cord tissue stem cells by partnering with institutions to establish FDA-regulated clinical trials for conditions that have no cure today.

Sensys Medical

Sensys Medical develops medical diagnostic instruments

Andro Diagnostics

AndroDx (Andro Diagnostics) is a medical device maker focused on making more accurate diagnostic tests for prostate cancer.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.